Pub Date : 2023-11-25DOI: 10.1007/s13669-023-00371-w
L. Sudhof, Sarah N. Bernstein
{"title":"Opioid Use Disorder: Approach to Intrapartum and Postpartum Management","authors":"L. Sudhof, Sarah N. Bernstein","doi":"10.1007/s13669-023-00371-w","DOIUrl":"https://doi.org/10.1007/s13669-023-00371-w","url":null,"abstract":"","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"435 18","pages":"199 - 208"},"PeriodicalIF":0.5,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139237035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-11DOI: 10.1007/s13669-023-00370-x
Arthur J. Vaught
{"title":"Peripartum Sepsis","authors":"Arthur J. Vaught","doi":"10.1007/s13669-023-00370-x","DOIUrl":"https://doi.org/10.1007/s13669-023-00370-x","url":null,"abstract":"","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135041614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-28DOI: 10.1007/s13669-023-00368-5
K. Albrecht, M. Tolcher
{"title":"Intrapartum Management of Moderate to Severe COVID-19: an Evidence-Based Update","authors":"K. Albrecht, M. Tolcher","doi":"10.1007/s13669-023-00368-5","DOIUrl":"https://doi.org/10.1007/s13669-023-00368-5","url":null,"abstract":"","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"12 1","pages":"165 - 172"},"PeriodicalIF":0.5,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48838599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-14DOI: 10.1007/s13669-023-00367-6
Sadhana Roop, Shian Patel, Michelle Zhang, V. Tran, L. Boucher, C. Reinhold, J. Pelage
{"title":"Uterine Artery Embolization for Adenomyosis: A Review of Imaging, Techniques, Complications and Outcomes","authors":"Sadhana Roop, Shian Patel, Michelle Zhang, V. Tran, L. Boucher, C. Reinhold, J. Pelage","doi":"10.1007/s13669-023-00367-6","DOIUrl":"https://doi.org/10.1007/s13669-023-00367-6","url":null,"abstract":"","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"12 1","pages":"186 - 197"},"PeriodicalIF":0.5,"publicationDate":"2023-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43403559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-08DOI: 10.1007/s13669-023-00365-8
L. Nommsen-Rivers, Hatice Cetinkaya, A. Stuebe
{"title":"Enabling Breastfeeding for Women with Obesity","authors":"L. Nommsen-Rivers, Hatice Cetinkaya, A. Stuebe","doi":"10.1007/s13669-023-00365-8","DOIUrl":"https://doi.org/10.1007/s13669-023-00365-8","url":null,"abstract":"","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"12 1","pages":"147 - 157"},"PeriodicalIF":0.5,"publicationDate":"2023-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42642982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-06DOI: 10.1007/s13669-023-00364-9
S. Young, Nuria Luna Ramirez, R. Kho
{"title":"Adenomyosis: Transvaginal Ultrasound and Imaging Innovations for Diagnosis","authors":"S. Young, Nuria Luna Ramirez, R. Kho","doi":"10.1007/s13669-023-00364-9","DOIUrl":"https://doi.org/10.1007/s13669-023-00364-9","url":null,"abstract":"","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"1 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42844542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-03DOI: 10.1007/s13669-023-00366-7
Laura A Smith, Brett C Young
Purpose of review: Our review focuses on the appropriate use of intravenous iron to increase the likelihood of achieving target hemoglobin levels prior to delivery to reduce maternal morbidity.
Recent findings: Iron deficiency anemia (IDA) is a leading contributor to severe maternal morbidity and mortality. Prenatal treatment of IDA has been demonstrated to reduce the likelihood of adverse maternal outcomes. Recent investigations of intravenous iron supplementation have demonstrated superior efficacy and high tolerability for the treatment of IDA in the third trimester, compared against oral regimens. However, it is unknown whether this treatment is cost-effective, available to clinicians, or acceptable to patients.
Summary: Intravenous iron is superior to the oral treatment of IDA; however, its use is limited by the lack of implementation data.
{"title":"Antenatal Optimization of Maternal Anemia Leads to Decreased Risks of Maternal Morbidity.","authors":"Laura A Smith, Brett C Young","doi":"10.1007/s13669-023-00366-7","DOIUrl":"10.1007/s13669-023-00366-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>Our review focuses on the appropriate use of intravenous iron to increase the likelihood of achieving target hemoglobin levels prior to delivery to reduce maternal morbidity.</p><p><strong>Recent findings: </strong>Iron deficiency anemia (IDA) is a leading contributor to severe maternal morbidity and mortality. Prenatal treatment of IDA has been demonstrated to reduce the likelihood of adverse maternal outcomes. Recent investigations of intravenous iron supplementation have demonstrated superior efficacy and high tolerability for the treatment of IDA in the third trimester, compared against oral regimens. However, it is unknown whether this treatment is cost-effective, available to clinicians, or acceptable to patients.</p><p><strong>Summary: </strong>Intravenous iron is superior to the oral treatment of IDA; however, its use is limited by the lack of implementation data.</p>","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":" ","pages":"1-7"},"PeriodicalIF":0.5,"publicationDate":"2023-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9769380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose of review: This report will review existing literature on weight loss outcomes for various anti-obesity medications (AOMs) as well as their effects on human fertility, pregnancy, or breastfeeding.
Recent findings: There is a paucity of research on the effects of AOMs on human pregnancy and fertility. The majority of AOMs are not recommended during pregnancy and breastfeeding due to known or unclear risks of harm to offspring.
Summary: As the prevalence of obesity rises, AOMs have proven to be effective tools for weight loss in the general adult population. When prescribing AOMs to reproductive-aged women, providers should consider both the cardiometabolic benefits of these medications and potential effects that AOMs might have on hormonal contraception, pregnancy, or breastfeeding. Animal studies in rats, rabbits, and monkeys have suggested teratogenic effects of several medications discussed in this report. However, a lack of data on the use of many AOMs during human pregnancy or lactation makes it difficult to comment on the safety of their use in these time periods. Some AOMs show promise in promoting fertility while others might decrease the efficacy of oral contraceptives, highlighting some of the special considerations that must be taken when prescribing AOMs to reproductive-aged women. More research into the risks and benefits of AOMs in the context of reproductive-aged women's unique healthcare needs is an important step in improving this population's access to effective treatments for obesity.
{"title":"Pharmacologic Treatment of Obesity in Reproductive Aged Women.","authors":"Akua Nuako, Lucy Tu, Karen J Campoverde Reyes, Shradha M Chhabria, Fatima Cody Stanford","doi":"10.1007/s13669-023-00350-1","DOIUrl":"10.1007/s13669-023-00350-1","url":null,"abstract":"<p><strong>Purpose of review: </strong>This report will review existing literature on weight loss outcomes for various anti-obesity medications (AOMs) as well as their effects on human fertility, pregnancy, or breastfeeding.</p><p><strong>Recent findings: </strong>There is a paucity of research on the effects of AOMs on human pregnancy and fertility. The majority of AOMs are not recommended during pregnancy and breastfeeding due to known or unclear risks of harm to offspring.</p><p><strong>Summary: </strong>As the prevalence of obesity rises, AOMs have proven to be effective tools for weight loss in the general adult population. When prescribing AOMs to reproductive-aged women, providers should consider both the cardiometabolic benefits of these medications and potential effects that AOMs might have on hormonal contraception, pregnancy, or breastfeeding. Animal studies in rats, rabbits, and monkeys have suggested teratogenic effects of several medications discussed in this report. However, a lack of data on the use of many AOMs during human pregnancy or lactation makes it difficult to comment on the safety of their use in these time periods. Some AOMs show promise in promoting fertility while others might decrease the efficacy of oral contraceptives, highlighting some of the special considerations that must be taken when prescribing AOMs to reproductive-aged women. More research into the risks and benefits of AOMs in the context of reproductive-aged women's unique healthcare needs is an important step in improving this population's access to effective treatments for obesity.</p>","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"12 2","pages":"138-146"},"PeriodicalIF":0.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328448/pdf/nihms-1884086.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9815188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1007/s13669-023-00359-6
Alexa King, Elizabeth E. Gerard
{"title":"Updates on Anti-seizure Medication Use in Pregnancy","authors":"Alexa King, Elizabeth E. Gerard","doi":"10.1007/s13669-023-00359-6","DOIUrl":"https://doi.org/10.1007/s13669-023-00359-6","url":null,"abstract":"","PeriodicalId":44726,"journal":{"name":"Current Obstetrics and Gynecology Reports","volume":"12 1","pages":"37 - 44"},"PeriodicalIF":0.5,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43806728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号